Role of BPC-157 in preclinical studies BPC-157 , also known as Body Protection Compound-157, is the subject of numerous studies in cellular and animal models for its cytoprotective and regenerative activity
MCC microcrystalline cellulose mannitol mannitol starch sorbitol and/or lactose lactose lactose the solid oral pharmaceutical composition may comprise one or more solubility enhancers, such as, e.g., poly(ethylene glycol), including poly(ethylene glycol) having a molecular weight in the range of about 200 to about 5,000 Da, ethylene glycol, propylene glycol, non-ionic surfactants, tyloxapol, polysorbate 20, polysorbate 80, macrogol-15-hydroxystearate, phospholipids, lecithin, dimyristoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine, distearoyl phosphatidylcholine, cyclodextrins, a-cyclodextrin, P-cyclodextrin, y-cyclodextrin, hydroxyethyl-P-cyclodextrin, hydroxypropyl-p-cyclodextrin, hydroxyethyl-y-cyclodextrin, hydroxypropyl-y-cyclodextrin the solid oral pharmaceutical composition may comprise one or more pharmaceutically acceptable carriers
$80.00 View Growth Hormone CJC-1295 (No DAC) 10 mg Short-acting GHRH analog
Activation of the Hippo pathway keeps the differentiated epithelium in a quiescent state
